These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16010846)

  • 1. Candida biofilm: a well-designed protected environment.
    Mukherjee PK; Zhou G; Munyon R; Ghannoum MA
    Med Mycol; 2005 May; 43(3):191-208. PubMed ID: 16010846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Candida albicans biofilm.
    Tsui C; Kong EF; Jabra-Rizk MA
    Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm of Candida albicans: formation, regulation and resistance.
    Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
    J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to build a biofilm: a fungal perspective.
    Blankenship JR; Mitchell AP
    Curr Opin Microbiol; 2006 Dec; 9(6):588-94. PubMed ID: 17055772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.
    Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA
    J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics for the analysis of the Candida albicans biofilm lifestyle.
    Thomas DP; Bachmann SP; Lopez-Ribot JL
    Proteomics; 2006 Nov; 6(21):5795-804. PubMed ID: 17001605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Abundances of Candida albicans and Candida glabrata in
    Olson ML; Jayaraman A; Kao KC
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal susceptibility of Candida albicans in biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Presterl E
    Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity against Candida biofilms.
    Iñigo M; Pemán J; Del Pozo JL
    Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
    Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
    mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescence Imaging to Study Mature Biofilm Formation by Candida spp. and Antifungal Activity In Vitro and In Vivo.
    Van Dyck K; Van Dijck P; Vande Velde G
    Methods Mol Biol; 2020; 2081():127-143. PubMed ID: 31721122
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ponde NO; Lortal L; Ramage G; Naglik JR; Richardson JP
    Crit Rev Microbiol; 2021 Feb; 47(1):91-111. PubMed ID: 33482069
    [No Abstract]   [Full Text] [Related]  

  • 14. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis.
    Zarnowski R; Sanchez H; Covelli AS; Dominguez E; Jaromin A; Bernhardt J; Mitchell KF; Heiss C; Azadi P; Mitchell A; Andes DR
    PLoS Biol; 2018 Oct; 16(10):e2006872. PubMed ID: 30296253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
    Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Identification of Biofilm-Specific Proteolysis in Candida albicans.
    Winter MB; Salcedo EC; Lohse MB; Hartooni N; Gulati M; Sanchez H; Takagi J; Hube B; Andes DR; Johnson AD; Craik CS; Nobile CJ
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans
    Rollenhagen C; Agyeman H; Eszterhas S; Lee SA
    mSphere; 2021 Oct; 6(5):e0070721. PubMed ID: 34585966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis uncovers the modulation of ergosterol, sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida albicans.
    Prasath KG; Sethupathy S; Pandian SK
    J Proteomics; 2019 Sep; 208():103503. PubMed ID: 31454558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation.
    Lee JA; Robbins N; Xie JL; Ketela T; Cowen LE
    PLoS Genet; 2016 Nov; 12(11):e1006452. PubMed ID: 27870871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.